The last year has seen several waves of federal policy updates affecting healthcare as President Donald Trump and his administration took on the first year of his second term in office. Here are eight ...
Because the Food and Drug Administration doesn’t routinely test generic drugs for quality, ProPublica engaged an independent ...
Atea Pharmaceuticals (AVIR) offers a late-stage, best-in-class HCV cure, with significant upside, currently trading below cash. BEM/RZR combines advantages of current first-line HCV therapies — single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback